Sex differences in self-reported executive function, anxiety and depression symptoms among young adults in substance use disorder treatment.

Authors

Morgan Scarth, Astrid Bjørnebekk, Espen Walderhaug

Published in

Journal of substance use and addiction treatment. Pages 210134. Oct 03, 2026. Epub Oct 03, 2026.

Abstract

Substance use disorders (SUD) are more prevalent among males than females, but recent evidence suggests this gap is narrowing. This shift highlights the need to better understand sex differences in cognitive and psychological characteristics among individuals with SUD. This study aims to explore sex differences in self-reported executive functioning and psychological distress and their associations with severity of SUD symptoms among young adults in SUD treatment.
Data were collected from 97 inpatients (mean age = 23.3 ± 2.6 years) at a SUD treatment center for young adults in Oslo, Norway. Within two weeks of admission, participants completed questionnaires evaluating alcohol and drug-related problems, executive functioning, and psychological distress at intake. These measures were compared between males and females using Welch's t-tests, and the relationships between psychological distress and executive function and severity of drug-related problems were evaluated using Spearman's correlations and linear regression in the whole sample and within each sex.
Both males (n = 65) and females (n = 32) reported high levels of polysubstance use. A majority of the sample scored above the clinical cut-off levels for executive dysfunction (71%) and psychological distress (85%). Females reported more executive function challenges than males in several areas including emotional control (p_FDR < 0.001) and working memory (p_FDR = 0.003). Regression analyses demonstrated associations between increased executive dysfunction and psychological distress and severity of drug use disorder in the whole sample and among males.
These findings emphasize the high psychiatric comorbidity among SUD patients, with females showing elevated executive dysfunction alongside anxiety symptoms. Females in SUD treatment may represent a more clinically severe subgroup. Routine assessment of executive functioning is warranted, and future studies should clarify these associations and their relevance for targeted interventions.

PMID:
42829205
Bibliographic data and abstract were imported from PubMed on 04 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.